NanoViricides Stock Price, News & Analysis (NYSEAMERICAN:NNVC)

$1.01 0.01 (1.00 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$1.00
Today's Range$1.00 - $1.02
52-Week Range$0.91 - $1.64
Volume34,626 shs
Average Volume92,598 shs
Market Capitalization$68.40 million
P/E RatioN/A
Dividend YieldN/A

About NanoViricides (NYSEAMERICAN:NNVC)

NanoViricides, Inc. is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the issues of viral diseases. The Company's nanoviricide technology enables direct attacks at multiple points on a virus particle. In addition, the nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection.

Receive NNVC News and Ratings via Email

Sign-up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS($0.15)
Net IncomeN/A
Net MarginsN/A
Return on Equity-48.03%
Return on Assets-36.92%


Outstanding Shares68,830,000

NanoViricides (NYSEAMERICAN:NNVC) Frequently Asked Questions

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NNVC."

How were NanoViricides' earnings last quarter?

NanoViricides, Inc. (NYSEAMERICAN:NNVC) announced its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.03) EPS for the quarter. View NanoViricides' Earnings History.

When will NanoViricides make its next earnings announcement?

NanoViricides is scheduled to release their next quarterly earnings announcement on Monday, February, 12th 2018. View Earnings Estimates for NanoViricides.

Are investors shorting NanoViricides?

NanoViricides saw a drop in short interest in the month of November. As of November 30th, there was short interest totalling 1,026,735 shares, a drop of 28.3% from the November 15th total of 1,431,399 shares. Based on an average daily volume of 131,481 shares, the days-to-cover ratio is currently 7.8 days. Currently, 1.9% of the shares of the company are short sold.

Who are some of NanoViricides' key competitors?

Who are NanoViricides' key executives?

NanoViricides' management team includes the folowing people:

  • Anil Diwan Ph.D., Chairman of the Board, President (Age 57)
  • Eugene Seymour M.D., Chief Executive Officer, Director (Age 75)
  • Meeta Vyas, Chief Financial Officer (Age 57)
  • Milton Boniuk, Independent Director (Age 83)
  • Stanley Glick CPA, Independent Director (Age 79)
  • Mukund S. Kulkarni Ph.D., Independent Director (Age 68)

How do I buy NanoViricides stock?

Shares of NanoViricides can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NanoViricides' stock price today?

One share of NanoViricides stock can currently be purchased for approximately $1.01.

How big of a company is NanoViricides?

NanoViricides has a market capitalization of $68.40 million.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Dr, SHELTON, CT 06484-6153, United States. The company can be reached via phone at +1-203-9376137.

MarketBeat Community Rating for NanoViricides (NNVC)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  20 (Vote Underperform)
Total Votes:  52
MarketBeat's community ratings are surveys of what our community members think about NanoViricides and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

NanoViricides (NYSEAMERICAN:NNVC) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


NanoViricides (NYSEAMERICAN:NNVC) Earnings History and Estimates Chart

Earnings by Quarter for NanoViricides (NYSEAMERICAN:NNVC)

NanoViricides (NYSEAMERICAN NNVC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/12/2018N/AView Earnings Details
11/14/2017Q1 2018($0.03)ViewN/AView Earnings Details
2/25/2015Q215($0.05)($0.03)$1.75 million$1.82 millionViewN/AView Earnings Details
10/2/2014($0.04)($0.07)ViewN/AView Earnings Details
5/20/2014($0.04)($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


NanoViricides (NYSEAMERICAN:NNVC) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for NanoViricides (NYSEAMERICAN:NNVC)

No dividend announcements for this company have been tracked by

Insider Trades

NanoViricides (NYSEAMERICAN NNVC) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for NanoViricides (NYSEAMERICAN:NNVC)

NanoViricides (NYSEAMERICAN NNVC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/22/2015Milton BoniukDirectorBuy25,000$1.30$32,500.00View SEC Filing  
9/11/2015Milton BoniukDirectorBuy50,000$1.02$51,000.00View SEC Filing  
8/26/2015Milton BoniukDirectorBuy50,000$1.05$52,500.00View SEC Filing  
7/8/2015Milton BoniukDirectorBuy50,000$1.58$79,000.00View SEC Filing  
5/20/2015Milton BoniukDirectorBuy50,000$1.60$80,000.00View SEC Filing  
5/8/2015Milton BoniukDirectorBuy405,954$2.58$1,047,361.32View SEC Filing  
1/12/2015Anil DiwanMajor ShareholderBuy14,000$2.56$35,840.00View SEC Filing  
1/6/2015Milton BoniukDirectorBuy25,000$2.60$65,000.00View SEC Filing  
12/9/2014Milton BoniukDirectorBuy50,000$3.05$152,500.00View SEC Filing  
7/17/2014Milton BoniukDirectorBuy57,144$3.50$200,004.00View SEC Filing  
2/20/2014Anil DiwanMajor ShareholderBuy50,000$3.61$180,500.00View SEC Filing  
10/21/2013Anil DiwanMajor ShareholderSell142,000$5.29$751,180.00View SEC Filing  
(Data available from 1/1/2013 forward)


NanoViricides (NYSEAMERICAN NNVC) News Headlines

NanoViricides, Inc. (NNVC) Sees Significant Decline in Short InterestNanoViricides, Inc. (NNVC) Sees Significant Decline in Short Interest - December 12 at 2:26 AM
NanoViricides, Inc. (NNVC) Short Interest UpdateNanoViricides, Inc. (NNVC) Short Interest Update - November 27 at 9:30 PM
NanoViricides Files Quarterly Report for Period Ending September 30, 2017NanoViricides Files Quarterly Report for Period Ending September 30, 2017 - November 21 at 8:40 AM
Is NanoViricides Inc (NNVC) A Financially Sound Company?Is NanoViricides Inc (NNVC) A Financially Sound Company? - November 21 at 8:40 AM

SEC Filings

NanoViricides (NYSEAMERICAN:NNVC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


NanoViricides (NYSEAMERICAN:NNVC) Income Statement, Balance Sheet and Cash Flow Statement


NanoViricides (NYSEAMERICAN NNVC) Stock Chart for Saturday, December, 16, 2017

Loading chart…

This page was last updated on 12/16/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.